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1. Introduction
  Anxiety disorders are the most common psychiatric 
disorders[1]. They accounts for heavy burden on public 
health. Present epidemiological data gives a different 
glimpse of this disorder, as traditionally thought, almost 
involving half of the population[2]. Every eighth human of 
total population is linked with anxiety, making this field 
an important area of research, for psychopharmacologist[3], 
hence it became need of an hour to develop new 
anxiolytics. Many secondary plant metabolites are 
reported in the treatment of psychological disorders. 
The anti anxiety activities plant metabolites are used in 
traditional medicine practice, either directly or indirectly 
affecting the central nervous system there by altering 
gamma-amino butyric acid, serotonin noradrenalin, 
benzodiazepine neurotransmitters activities. It is already 
proved that ursolic acid and its derivative is used in 
the treatment of central nerve system (CNS) disorders[4]. 
Ursolic acid obtained from Nepeta sibthorpii reported 
for CNS depressing, anticonvulsant and analgesic 
activity[5]. Awad et al in 2009 also reported in-vitro assays 
of ursolic acid inhibited GABA-T by 20% at a dose of
100 毺g/mL[6].
  Lantana camara  (L. camara )  L.  is  well  known 
traditional and tropical folk medicine[7-11]. Ursolic acid 
a stearoyl glucoside (UASG), pentacyclic triterpenoid 
was isolated from L. camara L. (family: verbanaceae)[12].
The traditional uses of L. camara L. mainly refer for 
the treatment of asthma, ulcers, measles, chickenpox, 
eczema, tumors, cancers, high blood pressure, bilious 
fevers, catarrhal infections, tetanus, rheumatism, malaria, 
ataxy of abdominal viscera[13,14], epilepsy[15], memory 
weakness, enhance intellect and cognition[16]. The plant 
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is reported to posses anticonvulsant[17], anticancer[18,19], 
antiulcer[20], antioxidant[19], anti-diabetic[21,22], antifungal, 
antibacterial[23-25], anti-feedant, larval mortality/
repellency[2],  antimotility[29],  analgesic and anti-
inflammatory activities[30].
  In Indian traditional herbal medicine, it is reported for 
its use in treatment of mental disorders and found to be 
effective as a brain tonic. Hence, our this work was an effoert 
to use UASG isolated from L. camara L. for its  anxiolytic 
effect against elevated plus-maze test (EPM), open field test 
and light and dark test induced anxiety in experimental 
animals.
2. Materials and methods
2.1. Animals 
  The experimental mice were obtained from the animal 
house of Siddhartha Institute of Pharmacy, Dehradun, India, 
(1435/PO/a/11/CPCSEA). The animals were housed as per the 
guide lines of CPCSEA. All the animals were provided with 
standard pellet diet (Lipton rat feed, Ltd., Pune) and water ad 
libitum throughout the experimental protocol. All the animal 
studies were approved by the Institutional Animal Ethical 
Committee of Siddhartha Institute of Pharmacy, Dehradun, 
India. The animals were randomly segregated into four 
groups, having six mice in each group. Group 栺, solvent 
control (received 0.9% (w/v) of saline); Group 栻, a positive 
control (diazepam 1 mg/kg); Group 栿 and 桇 were received 
UASG 25 and 50 mg/kg suspended in 1% Tween 80 (v/v). All 
the animals were administered with above drugs/solvent etc 
intraperitoneally, 30 min prior to start the experiment.
2.2. Plant material
 
  L. camara L. leaves were collected from Dehradun and 
identified by Dr. S. B. Singh, Scientist, NISCAIR, New Delhi. 
A voucher specimen (NISCAIR/RHMD/consult/-20-09-
10/1322/125) was deposited in the herbarium of NISCAIR, 
India.
2.3. Extraction and isolation of UASG
 
  Dried powder of Lantana camara leaves (4 kg) was 
extracted with methanol (12 L) at 50 曟 for 1 d. Extract was 
concentrated to dryness under reduced pressure to obtain 
slurry (605 g).
  The slurry was dissolved in minimum amount of methanol 
and was adsorbed on silica gel (60-120 mesh). The slurry was 
subjected to a silica gel column using CHCl3/ MeOH gradient 
system (49:1; 2.0 L for gradient system). It leads to elution 
of colorless crystals of USAG (yield 11.2 g, 0.28%). It was 
found to be 100% pure by HPTLC by using solvent system 
CHCl3/MeOH (99:1). Structure of compound was identified 
by comparison of their spectroscopic data from the reported 
literature[12]. The structure of USAG is depicted in Figure 1.
Figure 1.  Structure of ursolic acid stearoyl glucoside.
2.4. Chemicals
  Diazepam (Ranbaxy, New Delhi, India) was purchased 
through institution. All the chemicals were of analytical 
grade. Tween 80 (1% v/v) in saline was used to suspend UASG 
and was kept for its use.
2.5. Behavioral parameters used to test anxiolytic activity
2.5.1. Elevated plus-maze test (EPM)
  The EPM an apparatus designed by institute with following 
dimensions four arms elevated 25 cm from the floor. Each 
arm is at 90°relative to the adjacent arms. Two arms 
enclosed with high walls (35 cm伊5 cm伊20 cm), and the 
other two linked via a central area (5 cm伊5 cm) giving an 
appearance of plus sign. The maze floor and the walls of 
enclosed arms were black. An illumination with a 40 W lamp 
was made in the room. The animals were administered with 
vehicle, diazepam (1 mg/kg)[31] and USAG (25 and 50 mg/kg)
intraperitoneally, 30 min prior to the test. Initially the mice 
were accustomed to lab condition half an hour prior to 
behavioral testing.
  Each animal was individually placed on the central 
platform. The movement and duration of entries into the 
closed and open arms were observed for 5 min. Complete 
entry was considered and counted only when all four paws 
of the mouse entered an open or closed arm. The time spent 
(duration) in percentage for the open arms [100 伊 open/(open 
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+ enclosed)] and percentage of the number of open arm 
entries (frequency, 100 伊 open/total entries) were calculated 
for each mouse[32].
2.5.2. Open field test
  The apparatus designed with modification and dimensions 
of a wooden box (60 cm伊60 cm伊60 cm), was used. The area 
of open field was divided into 16 equal squares (15 cm伊
15 cm). The 12 squares were at the periphery and 4 inner 
squares in the center. The experimental was performed 
in, dark room with sound proof facility. The open field 
area was illuminated with a 40 W lamp, focusing from the 
height of 75-100 cm. Treatment was started with vehicle, 
diazepam (1 mg/kg) and USAG (25 and 50 mg/kg), by placing 
individual animal in one of the corner squares and number 
of rearing, assisted rearing (forepaws touching the walls of 
the apparatus) and number of squares crossed were noticed 
for 5 min[33].
2.5.3. Light and dark test
  The Light and dark test apparatus is  top open wooden box, 
with two distinct chambers, a black  (25 cm long 伊35 cm 
wide 伊35 cm deep), and  white which is illuminated with
40 W  light source as white, was  placed approx. 25 cm above 
the open box. The two chambers were linked with a small 
opening, (7.5 cm long 伊5.0 cm wide) located on the floor level 
at the center. The individual animal was placed in center of 
the light box and was observed for 5 min[34].
3. Result 
  As per our results animal treated with vehicle spent (53.29依
1.52) s in open arm and it’s time for closed arm was recorded 
as (135.40依1.62) s with demonstrating the number of (4.86依
0.28) entries in open arm and (33.85依0.74) in closed arm. The 
animal showed the increased stability in the open arm when 
treated with Diazepam (1 mg/kg) and UASG (25 and 50 mg/kg),
significantly (P<0.05 and P<0.001, respectively), whereas 
significant (P<0.01 and P<0.001, respectively) reduction was 
observed in number of entries and time spent in closed arm. 
UASG (25 and 50 mg/kg) and diazepam significantly (P<0.001) 
increased the percentage of time spent and entries in open 
arm (Table 1).
   84.85依1.58 squares were crossed by vehicle-treated 
animal and demonstrated (17.35依0.44) self rearing and 18.90
依0.88 assisted rearing during the interval of 5 min. when 
the animals were treated with Diazepam and UASG (25 and 
50 mg/kg), significant (P<0.05 and P<0.001, respectively) 
increase was noticed in the number of squares crossed by 
the animals. The self rearing and assisted rearing was altered 
significantly (P<0.05 and P<0.001, respectively) ie. increased 
by UASG (25 and 50 mg/kg) and diazepam (Table 2). The 
animals treated with diazepam (1 mg/kg) and UASG (25 and 
50 mg/kg) showed significant change (P<0.05, P<0.001 and 
P<0.001, respectively) i,e their  time spent in the lighted box 
was increased and decrease the dark box. UASG (25 mg/kg)
failed to bring any significant change in the number of 
crossing and duration of immobility, where as diazepam 
(1 mg/kg) and UASG (50 mg/kg) really showed significant 
(P<0.05 and P<0.01, respectively) increase in the number of 
crossing and decrease in the duration of immobility (Table 
3).
Table 1
Effect of UASG on behavior of mice in elevated plus maze test.
Treatment (mg/kg, i.p.)
No. of entries Time spent (s)
%OAE TSOA (s)
Open arm Closed arm Open arm Closed arm
Vehicle 4.86依0.28 33.85依0.74 53.29依1.52 135.40依1.62     23.74依0.74 35.90依0.78
Diazepam (1)     9.88依0.63***    23.89依0.47***     74.55依1.41***      85.50依1.73***  49.58依1.79***     56.20依1.00***
UASG (25)  6.10依0.45*  17.62依0.24** 57.88依1.20   110.60依1.93**  52.36依2.05***    42.32依0.58**
UASG (50)     8.36依0.52***   20.01依0.38***    74.47依1.19***      86.85依1.71***  52.15依2.20***     54.87依1.16***
Values are the mean 依 SEM of 6 mice / treatment, Significant *P<0.05, **P<0.01 and ***P<0.001 compared with control.
Table 2
Effect of UASG on behavior of mice in open field test.
Treatment (mg/kg, i.p.) No. of rearing No. of assisted rearing No. of squares crossed
Vehicle 17.35依0.44 18.90依0.88  84.85依1.58
Diazepam (1)    31.67依1.46***    33.34依0.95***   172.80依1.36***
UASG (25)    27.99依0.40***  26.04依0.97** 105.40依1.10*
UASG (50)    28.92依1.64***   29.81依0.74***   147.90依1.34***
Values are the mean 依 SEM of 6 mice / treatment, Significant *P<0.05, **P<0.01 and ***P<0.001 compared with control.
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Table 3
Effect of UASG on behavior of mice in light and dark model.
Treatment (mg/kg, i.p.) Time spent in lighted box (s) Time spent in dark box (s) No. of crossing Duration of immobility (s)
Vehicle  86.35依1.51 201.10依2.01 24.13依1.98 37.85依2.92
Diazepam (1)    175.00依1.82***    121.40依2.62***  32.53依1.63*  28.17依2.31*
UASG (25)  106.20依1.50*   177.20依2.56** 26.04依1.35 34.16依2.23
UASG (50)    156.60依1.69***    125.30依2.39***   31.94依1.93*    25.63依1.65***
Values are the mean 依 SEM of 6 mice/treatment, Significant *P<0.05, **P<0.01 and ***P<0.001 compared with control.
4. Discussion
  Elevated plus maze, works on the fact that native mice has 
tendency to spend more time in closed arms as compared 
to open one. This may be due to fear  generated in the open 
space. Present study on UASG, is a  dose dependent , which 
induces significant increases  both in  the number of entries 
and time spent in the open arms, where as decreases the 
number of entries and time spent in the closed arm, proving 
its  anxiolytic nature[35].
  The open field model evaluates anxiety related activities 
characterized by the normal aversion of the animal to an 
open and bright area. Animals when subjected to change in 
their acclimatized location, expresses anxiety and fear[36]. 
UASG, in a dose dependent manner, significantly changes 
anxiety parameter that is the increase in the number of self 
rearing, number of assisted rearing and number of squares 
crossed, proving its anxiolytic effect by reducing such fearful 
behavior of animals in open field. The light and dark box 
method is a natural test for rodents which shows that they 
avoid bright places[37]. UASG may reduce the fear of animal 
which allows the animal to increase more the time in bright 
and open space. This effect may be due to the agonistic 
effect on GABA/benzodiazepine receptor complex. Ursolic 
acid and its derivatives crosses the blood brain barrier[38,39]. 
UASG is a derivative of ursolic acid. It is known to posses 
anxiolytic activity[6], and all the activities may be due to 
ursolic acid only. In conclusion, UASG exhibited significant 
activity in elevated plus maze, light and dark model and 
open field test induced anxiety models, proved its anxiolytic 
action. Exact mechanism of action needs a further detailed 
study.
Conflict of interest statement
  We declare that we have no conflict of interest.
Acknowledgements
  The authors are humbly thankful to Mr. Durga Verma 
(Chairman) and Mr. R.R. Aggarwal (Director) of Siddhartha 
Institute of Pharmacy, Dehradun, India for providing lab and 
library facilities.
References
[1]   Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, 
Eshleman S, et al. Lifetime and 12-month prevalence of DSM-
III-R psychiatric disorders in the United States: results from 
the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 
8-19.
[2]   Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk 
G, et al. How common are common mental disorders? Evidence 
that lifetime rates are doubled by prospective versus retrospective 
ascertainment. Psychol Med 2010; 39: 899-909. 
[3]   Eisenberg RB, Davis SL, Ettner S, Appel S, Wilkey M, Rompay 
V, et al. Trends in alternative medicine used in United States: 
Results of a follow up national survey. J Am Med Assoc 1998; 280: 
1569-1575.
[4]   Martin R, Carvalho-Tavares J, Hernandez M, Arnees M, Ruiz-
Gutierrez V, Niet ML. Beneficial actions of oleanolic acid in an 
experimental model of multiple sclerosis: A potential therapeutic 
role. Biochem Pharmacol 2010; 79: 198-120.
[5]   Taviano MF, Miceli N, Monforte MT, Tzakou O, Galati EM. 
Ursolic acid plays a role in Nepeta sibthorpii bentham CNS 
depressing effects. Phytother Res 2007; 21: 382-385.
[6]   Awad R, Muhammad A, Durst T, Trudeau VL. Bioassay guided 
fractionation of lemon balm (Melissa officinalis L.) using an in vitro 
measure of GABA transaminase activity.  Phytother Res 2009; 23: 
1075-1081.
[7]   Pour BM, Sasidhara S. In vivo toxicity study of Lantana camara. 
Asian Pac J Trop Biomed 2011: 230-223. 
[8]   Kalita S, Kumar G, Karthik L, Rao KV. In vitro antioxidant and 
DNA damage inhibition activity of aqueous extract of Lantana 
camara L. (Verbenaceae) leaves. Asian Pac J Trop Biomed 2012; 
2(Suppl 3): S1675-S1679.
[9]   Seth R, Mohan M, Singh P, Haider SZ, Gupta S, Bajpai I, et al. 
Chemical composition and antibacterial properties of the essential 
oil and extracts of Lantana camara Linn. from Uttarakhand 
(India). Asian Pac J Trop Biomed 2012; 2(Suppl 3): S1407-S1411.
[10] Kumar D, Kumar A, Prakash O. Pharmacognostic study of 
Lantana camara Linn. root. Asian Pac J Trop Dis 2012; 2(Suppl 
1): S42-S45.
[11] Kazmi I, Gupta G, Afzal M, Anwar F. Anticonvulsant and 
depressant-like activity of ursolic acid stearoyl glucoside isolated 
from Lantana camara L. (verbanaceae). Asian Pac J Trop Dis 
Imran Kazmi et al./Asian Pacific Journal of Tropical Medicine (2013)433-437 437
2012; 2(Suppl 1): S453-S456.
[12] Kazmi I, Rahman M, Afzal M, Gupta G, Saleem S, Afzal O, et al. 
Anti-diabetic potential of ursolic acid stearoyl glucoside: A new 
triterpenic glycosidic ester from Lantana camara. Fitoterapia 
2012; 83: 142-146.
[13] Ghisalberti EL. Lantana camara L. (Verbenaceae). Fitoterapia 
2000; 71: 467-486.
[14] Day MD, Wiley CJ, Playford J, Zalucki MP. Lantana: current 
management, status and future prospects. Australian Centre for 
International Agricultural Research: Canberra; 2003.
[15] Ganesh T, Sen T, Thilagam E, Thamotharan G, Loganathan 
T, Chakraborty R. Pharmacognostic and anti-hyperglycemic 
evaluation of Lantana camara (L.) var. aculeate leaves in alloxan-
induced hyperglycemic rats. Int J Res Pharm Sci 2010; 1(3): 
247-252.
[16] Adams M, Gmunder F, Hamburger M. Plants traditionally used in 
age related brain disorders: a survey of ethnobotanical literature. J 
Ethnopharmacol 2007; 113: 363-381.
[17] Bisi-Johnson MA, Obi CL, Hattori T, Oshima Y, Li S, Kambizi 
L, et al. Evaluation of the antibacterial and anticancer activities 
of some South African medicinal plants. BMC Complement Altern 
Med 2011; 11: 14-18. 
[18] Gomes de Melo J, de Sousa Araújo TA, Thijan Nobre de Almeida 
e Castro V, Lyra de Vasconcelos Cabral D, do Desterro Rodrigues 
M, Carneiro do  Nascimento S, et al. Antiproliferative activity, 
antioxidant capacity and tannin content in plants of semi-arid 
northeastern Brazil. Molecules 2010; 15: 8534-8542.
[19] Sathish R, Vyawahare B, Natarajan K. Antiulcerogenic activity 
of Lantana camara leaves on gastric and duodenal ulcers in 
experimental rats. J Ethnopharmacol 2011; 134: 195-197.
[20] Venkatachalam T, Kumar VK, Selvi PK, Maske AO, Anbarasan 
V, Kumar PS. Anti-diabetic activity of Lantana camara Linn 
fruits in normal and streptozotocin-induced diabetic rats. J Pharm 
Res 2011; 4: 1550-1552. 
[21] Garg SK, Shah MA, Garg KM, Farooqui MM, Sabir M. Anti-
lymphocytic immunosuppressive effects of Lantana camara leave 
in rats. Indian J Exp Biol 1997; 35: 1315-1318.
[22] Sinha P, Saxena SK. Effect of treating tomatoes with leaf extract of 
Lantana camara on development of fruit rot caused by Aspergillus 
niger in presence of Drosophila busckii. Indian J Exp Biol 1987; 
25: 143-144. 
[23] Rwangabo PC, Claeys M, Pieters L, Corthout J, Vanden Berghe 
DA, Vlietinck AK. Umuhengerin, a new antimicrobially active 
flavonoid from Lantana trifolia. J Nat Prod 1988; 51: 966-968. 
[24] Barreto F, Sousa E, Campos A, Costa J, Rodrigues F. 
Antibacterial activity of Lantana camara Linn and Lantana 
montevidensis Brig extracts from Cariri-Ceará, Brazil. J Young 
Pharm 2010; 2: 42-44.
[25] Pandey ND, Singh M, Tewari GC. Antifeeding repellent and 
insecticidal properties of some indigenous plant material against 
mustard saw Ify, Athalia pronuima klug. Indian J Ent 1977; 39: 
60-63. 
[26] Chavan SR, Nikam ST. Investigation of Lantana camara Linn 
(Verbenaceae) leaves for larvicidal activity. Bull Haffkin Inst 
1982; 10: 21-22. 
[27] Pandey UK, Srivastava A, Lekha C, Singh A. Efficacy of certain 
plant extracts against brinjal aphid Aphis gossypii Glover. Indian J 
Ent 1983; 45: 313-314.
[28] Sagar L, Sehgal R, Ojha S. Evaluation of antimotility effect of 
Lantana camara L. var. acuelata constituents on neostigmine 
induced gastrointestinal transit in mice. BMC Complement Altern 
Med 2005; 5: 18-23.
[29] Ghosh S, Das Sarma M, Patra A, Hazra B. Anti-inflammatory 
and anticancer compounds isolated from Ventilago madraspatana 
Gaertn., Rubia cordifolia Linn. and Lantana camara Linn. J 
Pharm Pharmacol 2010; 62: 1158-1166.
[30] Commission on Epidemiology and Prognosis, International League 
Against Epilepsy, 1993. Guidelines for epidemiologic studies on 
epilepsy. Epilepsia 1993; 34: 592-596.
[31] Kuribara H, Stavinoha WB, Maruyama Y. Honokiol, a putative 
anxiolytic agent extracted from magnolia bark, has no diazepam-
like side-effects in mice. J Pharm Pharmacol 1999; 51(1): 
97-103.
[32] Adeyemi OO, Yetmitan OK, Taiwo AE. Neurosedative and muscle 
relaxant activities of ethyl acetate extract of Baphia nitida AFZEL. 
J Ethnopharmacol 2006; 106: 312-316.
[33] Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L. 
(mulberry) leaves on anxiety in mice. Ind J Pharmacol 2008; 40: 
32-36.
[34] Ambavade SD, Mhetre NA, Tate VD, Bodhankar SL. 
Pharmacological evaluation of the extracts of Sphaeranthus indicus 
flowers on anxiolytic activity in mice. Ind J Pharmacol 2006; 38: 
254-259.
[35] Hellion-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy Ml, 
Heinichen O, Campuzano M, et al. The anxiolytic-like effects of 
Aloysia polystachya (Griseb) Moldenke (Verbenaceae) in mice. J 
Ethnopharmacol 2006; 105: 400-408.
[36] Mechan AO, Moran PM, Elliott M, Young AJ, Joseph MH, Green 
R. A comparison between dark agouti and Sprague-Dawely 
rats in their behavior on the elevated plus-maze, open field 
apparatus and activity meters and their response to diazepam. 
Psychopharmacology 1995; 121: 38-56.
[37] Bourin M, Hascoet M. The mouse light/dark box test. Eur J 
Pharmacol 2003; 463: 55-65.
[38] Tsai S, Yin MC. Antioxidative and anti-inflammatory protection 
of oleanolic acid and ursolic acid in PC12 cells. J Food Sci 2008; 
73(7): H174-H178.
[39] Martin R, Carvalho-Tavares J, Hernández M, Arnes M, Ruiz-
Gutiérrez V, Nieto ML. Beneficial actions of oleanolic acid in an 
experimental model of multiple sclerosis: A potential therapeutic 
role. Biochem Pharmacol 2010; 79(2): 198-208.
